Medicine Information

Bextra Withdrawal Could Be Just the Beginning for Pfizer

The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.

The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.

There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.

Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including, a site devoted to the withdrawn drug Bextra and, a site devoted to structured settlements.

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at

Health Essentials from Cleveland Clinic (blog)

Opioids May Not Be the Best Medicine for Chronic Back, Joint Pain
Health Essentials from Cleveland Clinic (blog)
A new study shows that opioid pain medications are no more effective than non-opioids when it comes to treating chronic pain. Advertising Policy. Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our ...

and more »

We Are Weill Cornell Medicine: Dr. Babacar Cisse
Cornell Chronicle
Babacar Cisse immigrated to the United States from Senegal with just $26 in his pocket and a lesson from his parents to always give back. Now a neurosurgeon, Cisse heeds those words in every interaction with his patients. “Being a neurosurgeon and a ...

KMTV - 3 News Now

Quadruplets born at Nebraska Medicine
KMTV - 3 News Now
(KMTV) - For the first time since 2008, a set of quadruplets were born at Nebraska Medicine. On Feb. 23, Shalee and Andy McCarter of Overton welcomed the four babies, who are now at home with their parents and 10-year-old sister Elle after spending ...

and more »

Israel's Rambam Hospital, Stanford University Medicine Co-Host Symposium on Medical Tech
A joint symposium by Israel's Rambam Health Care Campus and Stanford University Medicine was held earlier this week on the Stanford campus in Palo Alto, California, with the aim of exploring best practices and the latest developments in clinical ...

and more »

Clinical Medicine Training Preps Med Students to Treat Transgender Patients
MD Magazine
A new study from Boston University School of Medicine suggests that medical students who are specifically trained in clinical transgender medicine are better prepared to treat transgender patients. Study authors demonstrated that specific transgender ...

Michigan Medicine's Division of Metabolism, Endocrinology and Diabetes showcases new research at Endocrine ...
University of Michigan Health System News (press release)
Members of the Michigan Medicine Division of Metabolism, Endocrinology and Diabetes are showcasing new research at the Endocrine Society's ENDO 2018 March 17-20 in Chicago. The annual meeting, taking place this year at McCormick Place West, is the ...

Valley morning Star

Reflecting on 30 years in medicine
Valley morning Star
While Susan's peers are beginning to retire, she cannot imagine a life outside of medicine. When asked what she would do if she wasn't a doctor, she sat back and contemplated a life without a white coat. It was hard. She likes history, so maybe a ...

Glasgow High School to offer advanced medicine career pathway
Bowling Green Daily News
Principal Amy Allen said GHS next year will begin offering the Advanced Medicine career pathway to students who want to become doctors, surgeons, pharmacists and other similarly advanced medical professions. “I'm really excited for our students because ...

and more »

Lab News

The future character of medicine - Laboratory News
Lab News
Nanotechnology offers great promise for the improvement of the treatment of a number of diseases. However, access to the expertise and methodologies required to characterise new nanomaterials is limited. The European Nanotechnology Characterisation ...

and more »

Greenville Journal

Furman University to offer new graduate degree program in community medicine
Greenville Journal
“It is important that the Master of Science in community engaged medicine be in alignment with Furman's mission and extend liberal arts and sciences values to students who are ultimately planning careers in health care,” said Victoria Turgeon ...

Google News

home | site map | Dr. Thad Thomas
© 2006